InvestorsHub Logo
Followers 44
Posts 864
Boards Moderated 0
Alias Born 03/08/2014

Re: skitahoe post# 483620

Tuesday, 06/07/2022 2:25:18 AM

Tuesday, June 07, 2022 2:25:18 AM

Post# of 694017
There is no doubt that NWBO has had discussions and guidance with and from the FDA. Especially since they have orphan designation which engenders such interactions and guidance from the FDA. There is no doubt in my mind that this relationship and now positive results from the trial has very favorably disposed the FDA towards an approval perhaps on or about the same time frame as the MHRA. I have to believe that with Dr. Ashkan’s known and vocal support, the MHRA, will act very expeditiously upon the submission of an application if it has not already been done so.

Dr. Bosch’s presentation was masterful and highly encouraging as they “have solved the three Ps “ After all, the manufacturing process is the product.

ASCO was not a nothing burger and these two superb presentations cast a wider net of information transfer of what we long term investors have already known. Highly encouraging to say the least.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News